TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 22 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 925 followers.

New article: TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia https://t.co/B2NjcA96Bq #CLL #leusm #hematology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.